Nicholas Argento, M.D. attended Georgetown University and graduated Magna Cum Laude with a BS in Biology, then the University of Maryland School of Medicine and graduated Cum Laude. He completed his residency in Internal Medicine and fellowship in Diabetes, Endocrine and Metabolism at the University of Maryland Medical System. He joined Maryland Endocrine full time in 1991. He has been the Medical Advisor to the diabetes program at Johns Hopkins Howard County Medical Center since 1995, and gives talks regularly to medical and patient audiences on diabetes. He has a strong interest in type 1 diabetes (T1D), and has extensive experience in utilizing insulin pumps and continuous glucose monitoring (CGM) to help patients safely achieve better blood glucose control. He has 4 publications in medical journals on different aspects of CGM use, and was co-author or contributor to multiple chapters in the 2013 American Diabetes Association book, Putting Your Patient On The Pump, 2nd edition. He has presented clinical research multiple times at the American Diabetes Association Scientific Sessions and other medical meetings, and has spoken to local, national, and international audiences on insulin pumps and the clinical application of CGM technology. He is very active on and lends medical support to and has written numerous articles for the T1DExchange website myglu.org, a website dedicated to outreach, research and engagement of and for the T1D community. For more information, visit marylandendocrine.com. Dr. Argento is rated as a Distinguished provider by MediFind in the treatment of Type 1 Diabetes (T1D). His top areas of expertise are Type 1 Diabetes (T1D), Hypothyroidism, Type 2 Diabetes (T2D), and Vitamin D Deficiency.

Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is rated as a Distinguished provider by MediFind in the treatment of Type 1 Diabetes (T1D). His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Dr. Mathioudakis, an endocrinologist and researcher, has a strong focus on diabetes management and patient care, recognized through awards like the Baltimore Top Doc. He has contributed significantly to diabetes research, authoring over 150 publications and participating in the development of consensus guidelines in the field. His studies have offered valuable insights into using health informatics for diabetes prevention and management. After graduating from the Johns Hopkins University School of Medicine and completing his training in Internal Medicine and a fellowship in Endocrinology, Diabetes, & Metabolism, Dr. Mathioudakis joined the faculty in the Division of Endocrinology, Diabetes & Metabolism in 2012. He earned a Master of Health Science in clinical investigation in 2015 and was the Clinical Director of the Division of Endocrinology from 2016 to 2021. Currently, he co-directs the Baltimore Metropolitan Diabetes Regional Partnership, focusing on improving access to diabetes prevention and management programs. As a physician-scientist, Dr. Mathioudakis leads multiple research studies funded by the NIH, private philanthropic organizations (Helmsley Charitable Trust), non-profit organizations (Breakthrough T1D), and industry. His research focuses on the effectiveness of automated diabetes prevention programs and strategies to reduce racial disparities in diabetes technology access. He also collaborates nationally to enhance care for people with type 1 diabetes. Holding a joint appointment in the Division of Biomedical Informatics and Data Science, Dr. Mathioudakis integrates machine learning and AI in diabetes research. He has served on the national Epic Endocrinology Specialty Steering Board and chaired the Type 2 Diabetes Prognostics Working Group for the Precision Medicine Diabetes Initiative. Committed to education, he frequently lectures on endocrinology, epidemiology, and health informatics. Dr. Mathioudakis is rated as a Distinguished provider by MediFind in the treatment of Type 1 Diabetes (T1D). His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Low Blood Sugar, Maturity Onset Diabetes of the Young, and Pancreaticoduodenectomy.

Sherita Golden is an Endocrinologist in Baltimore, Maryland. Dr. Golden is rated as a Distinguished provider by MediFind in the treatment of Type 1 Diabetes (T1D). Her top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Obesity, and Hormone Replacement Therapy (HRT).

Dr. Aniket Sidhaye is an assistant professor of medicine and pediatrics at the Johns Hopkins University School of Medicine. His specific clinical interests are cystic fibrosis related endocrine disorders, type 1 diabetes mellitus particularly emerging adults with diabetes, thyroid disorders, metabolic bone disease, and management of hospitalized persons with diabetes. Dr. Sidhaye earned his M.D. from Northwestern University’s Feinberg School of Medicine. He completed his residency at Northwestern University. He performed a research fellowship in endocrinology and metabolism at Northwestern University and also performed fellowships in endocrinology and metabolism at Johns Hopkins. His research interests include CF related diabetes, bone health of CF patients after lung transplant, and the care of emerging adults with type 1 diabetes. In addition, he is a committed educator serving as an advisor in the medical school, co-director for the endocrine course for pre-clinical medical students, and program director for our endocrine fellowship. Dr. Sidhaye is rated as a Distinguished provider by MediFind in the treatment of Type 1 Diabetes (T1D). His top areas of expertise are Type B Insulin Resistance Syndrome, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Paget's Disease of Bone.

Kashif Munir is an Endocrinologist in Baltimore, Maryland. Dr. Munir is rated as a Distinguished provider by MediFind in the treatment of Type 1 Diabetes (T1D). His top areas of expertise are Type 2 Diabetes (T2D), Thyroid Cancer, Thyroid Storm, Pituitary Tumor, and Thyroidectomy.

Robert Vigersky is an Endocrinologist in Bethesda, Maryland. Dr. Vigersky is rated as a Distinguished provider by MediFind in the treatment of Type 1 Diabetes (T1D). His top areas of expertise are Low Blood Sugar, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Jack Snitzer is an Endocrinologist in Salisbury, Maryland. Dr. Snitzer is rated as a Distinguished provider by MediFind in the treatment of Type 1 Diabetes (T1D). His top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Obesity in Children, and Toxic Nodular Goiter.

David Levitt is an Endocrinologist in Hanover, Maryland. Dr. Levitt is rated as a Distinguished provider by MediFind in the treatment of Type 1 Diabetes (T1D). His top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Hypothyroidism, and Hyperthyroidism.

Jean Park is an Endocrinologist in Baltimore, Maryland. Dr. Park is rated as a Distinguished provider by MediFind in the treatment of Type 1 Diabetes (T1D). Her top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Thyroid Storm.

Neha Vyas is a Pediatric Endocrinologist in Baltimore, Maryland. Dr. Vyas is rated as a Distinguished provider by MediFind in the treatment of Type 1 Diabetes (T1D). Her top areas of expertise are Type 1 Diabetes (T1D), Short Stature (Growth Disorders), Precocious Puberty, and Familial Short Stature (FSS).

Caroline Huang is an Endocrinologist in Lanham, Maryland. Dr. Huang is rated as a Distinguished provider by MediFind in the treatment of Type 1 Diabetes (T1D). Her top areas of expertise are Type 1 Diabetes (T1D), Hashimoto Thyroiditis, Obesity in Children, and Osteoporosis.

Kiarash Zarbalian is an Endocrinologist in Frederick, Maryland. Dr. Zarbalian is rated as a Distinguished provider by MediFind in the treatment of Type 1 Diabetes (T1D). His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Hypothyroidism, and Thyroid Nodule.

Noriecel Mendoza, MD, specializes in endocrinology and is board-certified in endocrinology, diabetes, and metabolism by the American Board of Internal Medicine. She practices at UPMC Western Maryland Endocrinology. Dr. Mendoza received her medical degree from the University of Santo Tomas and completed her residency at Albert Einstein College of Medicine, followed by a fellowship at the University of Arizona College of Medicine. Dr. Mendoza is rated as an Experienced provider by MediFind in the treatment of Type 1 Diabetes (T1D). Her top areas of expertise are Hyperparathyroidism, Hyperthyroidism, Thyroid Storm, and Type 2 Diabetes (T2D).

Dr. Han Na Kim is a Clinical Associate and part-time Assistant Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism. Her clinical practice focuses on metabolic bone disease, including osteoporosis and hyperparathyroidism, as well as diabetes mellitus. She earned her medical degree from the University of Chicago Pritzer School of Medicine, completed her residency in Internal Medicine at New York University, and worked as a hospitalist at University of Pittsburgh Medical Center Presbyterian/Montefiore before pursuing an endocrinology fellowship at Johns Hopkins University School of Medicine. She sees patients at the Johns Hopkins Bayview Metabolic Bone and Osteoporosis Center and Green Spring Station Johns Hopkins Endocrinology Clinic (diabetes and thyroid patients only). Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Type 1 Diabetes (T1D). Her top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Juvenile Primary Osteoporosis, and Hyperparathyroidism.

Mark Corriere is an Endocrinologist in Towson, Maryland. Dr. Corriere is rated as an Advanced provider by MediFind in the treatment of Type 1 Diabetes (T1D). His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Thyroid Nodule, and Hypothyroidism.

Vikram Shenoy, M.D., practices endocrinology at Johns Hopkins Community Physicians Downtown Bethesda. He received his medical degree from University of Connecticut School of Medicine, and also completed his residency in endocrinology at Hospital of the University of Pennsylvania. He practices general endocrinology, including the treatment of thyroid disorders, diabetes, PCOS, pituitary and adrenal disorders, hypogonadism and osteoporosis. Dr. Shenoy is rated as an Advanced provider by MediFind in the treatment of Type 1 Diabetes (T1D). His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), and Hypothyroidism.

Martin Sarkar is an Endocrinologist in Frederick, Maryland. Dr. Sarkar is rated as an Advanced provider by MediFind in the treatment of Type 1 Diabetes (T1D). His top areas of expertise are Hypothyroidism, Type 2 Diabetes (T2D), Obesity in Children, and Thyroid Nodule.

Justin Tcheugui is an Endocrinologist in Baltimore, Maryland. Dr. Tcheugui is rated as an Advanced provider by MediFind in the treatment of Type 1 Diabetes (T1D). His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), and Gestational Diabetes.

Rosalie Naglieri, M.D., is an endocrinologist with Johns Hopkins Community Physicians. Dr. Naglieri attended Upstate Medical University in Syracuse, New York where she received her medical degree. Her residency in internal medicine was served at University of Maryland Medical Center, where she went on to complete her fellowship in Endocrinology, Diabetes and Metabolism. Her interests include thyroid disease, thyroid cancer, diabetes, obesity and polycystic ovarian syndrome. She has been published in Diabetes Care, among other medical journals. When taking care of patients, Dr. Naglieri aims to take care of the whole person, not just their diagnosis. Dr. Naglieri loves being a doctor. She enjoys the relationships she develops with her patients and being their cheerleader in improving their health. Additionally, she has a special interest in plant-based nutrition and its benefits in preventing disease and improving overall health. After growing up in New York, Dr. Naglieri moved to Maryland over 20 years ago. She is married and has two children, a daughter and a son. Dr. Naglieri is rated as an Advanced provider by MediFind in the treatment of Type 1 Diabetes (T1D). Her top areas of expertise are Hypothyroidism, Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), and Type 1 Diabetes (T1D).